RSS feed

Publications by Halldis Oksefjell

13 publications found

Original articles

Tropé CG, Elstrand MB, Sandstad B, Davidson B, Oksefjell H (2012)
Neoadjuvant chemotherapy, interval debulking surgery or primary surgery in ovarian carcinoma FIGO stage IV?
Eur J Cancer, 48 (14), 2146-54
DOI 10.1016/j.ejca.2012.01.031, PubMed 22382201

Elstrand MB, Sandstad B, Oksefjell H, Davidson B, Tropé CG (2012)
Prognostic significance of residual tumor in patients with epithelial ovarian carcinoma stage IV in a 20 year perspective
Acta Obstet Gynecol Scand, 91 (3), 308-17
DOI 10.1111/j.1600-0412.2011.01316.x, PubMed 22050605

Zang RY, Harter P, Chi DS, Sehouli J, Jiang R, Tropé CG, Ayhan A, Cormio G, Xing Y, Wollschlaeger KM, Braicu EI, Rabbitt CA, Oksefjell H, Tian WJ, Fotopoulou C, Pfisterer J, du Bois A, Berek JS (2011)
Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort
Br J Cancer, 105 (7), 890-6
DOI 10.1038/bjc.2011.328, PubMed 21878937

Tian WJ, Chi DS, Sehouli J, Tropé CG, Jiang R, Ayhan A, Cormio G, Xing Y, Breitbach GP, Braicu EI, Rabbitt CA, Oksefjell H, Fotopoulou C, Meerpohl HG, du Bois A, Berek JS, Zang RY, Harter P (2011)
A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection
Ann Surg Oncol, 19 (2), 597-604
DOI 10.1245/s10434-011-1873-2, PubMed 21732142

Oksefjell H, Sandstad B, Tropé C (2011)
The role of surgery in the second relapse of epithelial ovarian cancer. Selection criteria, morbidity and survival outcome
Eur J Gynaecol Oncol, 32 (4), 369-76
PubMed 21941955

Oksefjell H, Sandstad B, Tropé C (2008)
The role of secondary cytoreduction in the management of the first relapse in epithelial ovarian cancer
Ann Oncol, 20 (2), 286-93
DOI 10.1093/annonc/mdn591, PubMed 18725390

Oksefjell H, Sandstad B, Tropé C (2008)
Is the watch and wait approach adequate after comprehensive surgical staging in invasive stage I epithelial ovarian cancer? The Norwegian Radium Hospital experience
Eur J Gynaecol Oncol, 29 (6), 583-9
PubMed 19115683

Liavaag AH, Dørum A, Bjøro T, Oksefjell H, Fosså SD, Tropé C, Dahl AA (2007)
A controlled study of sexual activity and functioning in epithelial ovarian cancer survivors. A therapeutic approach
Gynecol Oncol, 108 (2), 348-54
DOI 10.1016/j.ygyno.2007.10.009, PubMed 17996925

Oksefjell H, Sandstad B, Tropé C (2007)
Improved survival for stage IIIC ovarian cancer patients treated at the Norwegian Radium Hospital between 1984 and 2001
Eur J Gynaecol Oncol, 28 (4), 256-62
PubMed 17713088

Lyng H, Brøvig RS, Svendsrud DH, Holm R, Kaalhus O, Knutstad K, Oksefjell H, Sundfør K, Kristensen GB, Stokke T (2006)
Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer
BMC Genomics, 7, 268
DOI 10.1186/1471-2164-7-268, PubMed 17054779

Oksefjell H, Sandstad B, Trope C (2006)
Ovarian cancer stage IIIC. Consequences of treatment level on overall and progression-free survival
Eur J Gynaecol Oncol, 27 (3), 209-14
PubMed 16800244

Oksefjell H, Ipsen HE, Okland O (1990)
[Acid-base equilibrium in umbilical cord blood. Apgar score and acid-base equilibrium in umbilical cord blood as control parameters during labor]
Tidsskr Nor Laegeforen, 110 (2), 209-12
PubMed 2300956

Oksefjell H, Aure JC (1987)
[Cesarean section. Indications, incidence and complications]
Tidsskr Nor Laegeforen, 107 (2), 134-7
PubMed 3824298